Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ginkgo Bioworks logo — Making biology easier to engineer.

Ginkgo Bioworks

Making biology easier to engineer.

Founded 2009 United States Boston, United States 496 employees Unknown Total: $2.55B Biopharma, Biotechnology

General Information

Company Name Ginkgo Bioworks
Founded Year 2009
Location United States Boston, United States +4
Employees 496
Industries Biopharma, Biotechnology
Funding Stage Unknown
Social

Get notified when Ginkgo Bioworks moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Sep 15, 2026

Ginkgo Bioworks has been selected by Novo Nordisk to build an autonomous lab powered by its Reconfigurable Automation Cart (RAC) architecture.

Event Participation Sep 10, 2026

Ginkgo Bioworks' Project Director Susan Buckhout-White is participating as a panelist at the 2026 Emerging Technologies for Defense Conference & Exhibition, scheduled for September 10-11, 2026.

New Partnership Sep 10, 2026

Ginkgo Bioworks is partnering with Waterfall Scientific on the ESCALATOR project, a multi-organization effort for RNA drug manufacturing.

Grant Received Sep 10, 2026

Ginkgo Bioworks was awarded a subcontract for up to $17.5M under the ARPA-H GIVE program from the Advanced Research Projects Agency for Health.

Product Launch Sep 03, 2026

Ginkgo Bioworks has launched Ginkgo Reagents #CFPS Disulfide Premium, a new product designed to ensure proper oxidative folding and functional activity for complex targets. Orders are set to open o…

Partnership Talks Aug 24, 2026

Ginkgo Bioworks is inviting parties interested in collaborating on data-driven biotherapeutics to reach out, signaling initial partnership talks.

+1 more signal in last 30 days

Get alerts when Ginkgo Bioworks shows new signals

AI Insight

Bounce Watch AI
3 weeks ago

Ginkgo Bioworks is demonstrating significant strategic momentum, actively expanding its ecosystem and validating its advanced autonomous lab capabilities. Recent highlights include a key partnership with MIT Media Lab, the launch of a new service facilitating reagent integration for automated labs, and a major customer win with the Department of Energy commissioning their AMP2 lab. These actions signal a clear strategic shift towards broadening platform adoption through both direct client engagement and strengthening its supplier network.

Signal Types
Partnership Product Launch Customer Acquisition Recognition Efficiency Gain
Strategic Labels
Ecosystem Expansion Technology Validation Market Penetration
Next Move: Expansion
·
Impact: 8/10
·
Ideal For: Biotechnology Growth Investors – Public Equity

About Ginkgo Bioworks

Ginkgo Bioworks is pioneering advancements in the field of biotechnology by making biology easier to engineer, fulfilling its promise embodied in the slogan, "Making biology easier to engineer." Founded in 2009, this United States-based company operates at the intersection of Biopharma and Biotechnology.

By leveraging autonomous laboratories, Ginkgo Bioworks aims to revolutionize traditional laboratory processes through robotics, enhancing the productivity of scientists. Its innovative solutions, accessible via the "cloud lab" model, provide advanced Datapoints and Solutions contract research services, making lab operations more efficient and streamlined.

The company recently secured a Grant investment on 01 April 2024 from the Bill & Melinda Gates Foundation, highlighting confidence from major investors in its mission and technological acumen.

Taxonomy: Biological Engineering, Synthetic Biology, Automation in Laboratories, Cloud Lab Services, Custom Microbes, Molecular Discovery, Probiotic Development, Organism Licensing, Flavor and Sweetener Engineering, Cosmetic Ingredient Design, Crop Treatment Solutions, Pharmaceutical Applications, Carbon Mitigation, Metabolic Engineering, AI in Biotechnology

Services & Products

Building Autonomous Labs
Providing Cloud Lab Services
R&D Experiment Design
Ginkgo Solutions Team
Ginkgo Datapoints Services

Target Customers

Scientists Biotech Researchers Pharmaceutical Companies Biotech Startups R&D Professionals

Funding Rounds & Investors (21)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Apr 2024
Support Program •••••• 1
Investor
01 Jan 2024
Grant •••••• 1 •••• •••• 01 Sep 2023
Post Ipo Equity •••••• 1
Investor
01 Oct 2021
Spac Private Placement •••••• 1 •••• •••• 01 May 2021

View All 21 Funding Rounds

Latest News

View All
GM hires ex-Tesla, Google exec to replace retiring head of manufacturing — Cnbc
GM hires ex-Tesla, Google exec to replace retiring head of manufacturing
Cnbc Mar 14, 2024

Ginkgo Bioworks Alternatives & Competitors

View All Alternatives
Ginkgo Bioworks vs
Fermelanta, Inc.
Fermelanta, Inc. Japan

A Japan-based startup that makes plant-based chemicals by synthetic biology

Seed
16 employees
Biotechnology, Life Sciences
Compare Ginkgo Bioworks vs Fermelanta, Inc.
Ginkgo Bioworks vs
SilicoLife
SilicoLife Portugal

Unlocking access to pure ingredients through precision fermentation

Grant
22 employees
Biotechnology
Compare Ginkgo Bioworks vs SilicoLife
Ginkgo Bioworks vs
Ginkgo Bioworks
Ginkgo Bioworks United States

Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. We offer autonom...

524 employees
Also compare with: Ginkgo Bioworks vs National High Magnetic Field Laboratory National High Magnetic Field Laboratory View all alternatives

FAQ About Ginkgo Bioworks

Making biology easier to engineer.
Ginkgo Bioworks was founded in 2009.
Ginkgo Bioworks is headquartered in Boston, United States.
Ginkgo Bioworks operates in the following industries: Biopharma, Biotechnology.
Ginkgo Bioworks has approximately 496 employees.
Ginkgo Bioworks has completed 21 funding rounds, raising a total of $2.55B. The latest funding stage is Unknown.
Ginkgo Bioworks offers: Building Autonomous Labs, Providing Cloud Lab Services, R&D Experiment Design, Ginkgo Solutions Team, Ginkgo Datapoints Services.
Top alternatives and competitors to Ginkgo Bioworks include Fermelanta, Inc., SilicoLife, Ginkgo Bioworks, National High Magnetic Field Laboratory, Latent Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ginkgo Bioworks and Fermelanta, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ginkgo Bioworks and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy